Not Yet Another Negative Trial-ReACTing on Recent Glioblastoma Trials.

Wick, Wolfgang; Wagener, Robin J

Wick, Wolfgang; Wagener, Robin J.

Afiliação

Wick W; University Medical Center & German Cancer Research Center, Heidelberg, Germany. wolfgang.wick@med.uni-heidelberg.de.
Wagener RJ; University Medical Center & German Cancer Research Center, Heidelberg, Germany.

Clin Cancer Res ; 26(7): 1535-1537, 2020 04 01.

Article em En | MEDLINE | ID: mdl-32034079

ABSTRACT

ABSTRACT

The present ReACT trial provides data from a small randomized controlled vaccination trial that in addition to other recent immunotherapy trials in glioblastoma allows sketching a rational, advanced trial design for the development of (immune) therapies in glioblastoma elaborating on but not restricting to biological monitoring and endpoints.See related article by Reardon et al., p. 1586.

Assuntos

Neoplasias Encefálicas; Glioblastoma; Bevacizumab; Vacinas Anticâncer; Método Duplo-Cego; Receptores ErbB; Humanos; Imunoterapia; Pacientes; Vacinas de Subunidades Antigênicas

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google